Equities

GSK plc

GSK:LSE

GSK plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,329.14
  • Today's Change19.64 / 1.50%
  • Shares traded1.57m
  • 1 Year change-5.81%
  • Beta0.6040
Data delayed at least 20 minutes, as of Nov 22 2024 11:36 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4,9927,8774,335
Total Receivables, Net7,4037,1158,031
Total Inventory5,4985,1465,783
Prepaid expenses355343315
Other current assets, total396288210
Total current assets18,64420,76918,674
Property, plant & equipment, net9,9579,62010,672
Goodwill, net6,8117,04610,552
Intangibles, net14,76814,31830,079
Long term investments1,1921,5412,214
Note receivable - long term950965935
Other long term assets--018
Total assets59,00560,14679,103
LIABILITIES
Accounts payable3,7173,8664,535
Accrued expenses10,71110,58711,186
Notes payable/short-term debt1,0061,639802
Current portion long-term debt/capital leases1,8072,3132,799
Other current liabilities, total3,8274,4054,348
Total current liabilities21,06822,81023,670
Total long term debt15,20517,03520,572
Total debt18,01820,98724,173
Deferred income tax3112893,556
Minority interest(552)(502)6,287
Other liabilities, total9,6269,9169,963
Total liabilities45,65849,54864,048
SHAREHOLDERS EQUITY
Common stock1,3481,3471,347
Additional paid-in capital3,4513,4403,301
Retained earnings (accumulated deficit)9,3686,49210,073
Treasury stock - common------
Unrealized gain (loss)(510)(308)383
Other equity, total(22)(20)(21)
Total equity13,34710,59815,055
Total liabilities & shareholders' equity59,00560,14679,103
Total common shares outstanding4,0564,0344,025
Treasury shares - common primary issue256277284
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.